Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedhelm Sayk

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
United European Gastroenterology Journal|April 16, 2025
Minimal Hepatic Encephalopathy in Cirrhotic Patients: A New Simple and Fast Digital Screening MethodHenrike Dobbermann, Raffael Schlüter, Yevgeniy Lyubchenko, et al.
JAMA|March 15, 2012
Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4Martin Nitschke, Friedhelm Sayk, Christoph Härtel, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2025
PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feedingLina Jegodzinski, Lorena Rudolph, Darko Castven, et al.
Plos One|March 28, 2013
Risk factors for development of hemolytic uremic syndrome in a cohort of adult patients with STEC 0104:H4 infectionAlexander Zoufaly, Jakob P Cramer, Eik Vettorazzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2013
Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter studyRalf P Vonberg, Michael Höhle, Martin Aepfelbacher, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|December 16, 2025
[Core curriculum of intensive care and emergency medicine in internal medicine], , , et al.
BMJ (Clinical Research Ed.)|July 21, 2012
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control studyJan Menne, Martin Nitschke, Robert Stingele, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
United European Gastroenterology Journal|April 16, 2025
Minimal Hepatic Encephalopathy in Cirrhotic Patients: A New Simple and Fast Digital Screening MethodHenrike Dobbermann, Raffael Schlüter, Yevgeniy Lyubchenko, et al.
JAMA|March 15, 2012
Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4Martin Nitschke, Friedhelm Sayk, Christoph Härtel, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2025
PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feedingLina Jegodzinski, Lorena Rudolph, Darko Castven, et al.
Plos One|March 28, 2013
Risk factors for development of hemolytic uremic syndrome in a cohort of adult patients with STEC 0104:H4 infectionAlexander Zoufaly, Jakob P Cramer, Eik Vettorazzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2013
Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter studyRalf P Vonberg, Michael Höhle, Martin Aepfelbacher, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|December 16, 2025
[Core curriculum of intensive care and emergency medicine in internal medicine], , , et al.
BMJ (Clinical Research Ed.)|July 21, 2012
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control studyJan Menne, Martin Nitschke, Robert Stingele, et al.
Pageof 5